Dr Malinda Itchins

Researcher, Department of Medical Oncology, Royal North Shore Hospital,, University of Sydney
Dr Malinda Itchins BMedSci, MBBS(Hons1), PhD, FRACP, is a thoracic medical oncologist at Royal North Shore Hospital, GenesisCare, and North Shore Private. In 2020 she graduated from University of Sydney in her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically and clinically. Malinda is a Board Director and the Lung Cancer Chair of the Clinical Oncology of Australia (COSA), and Advanced NSCLC Co-Chair for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is Primary Investigator on multiple lung cancer clinical trials and her research focus to date has been in patterns of care, the real-world experience and drug resistance in oncogene driven lung cancers. She is passionate about the evolution of precision medicine and equity of access to care in thoracic cancers.

More from this expert

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting lung cancer earlier.

Clinical Articles iconClinical Articles